VANCOMYCIN HYDROCHLORIDE
| Brand name | FIRVANQ KIT |
|---|---|
| Active ingredient | VANCOMYCIN HYDROCHLORIDE |
| Strength | EQ 50MG BASE/ML |
| Dosage form | FOR SOLUTION |
| Route | ORAL |
| Modality | Small molecule |
| FDA approval | January 2018 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 10959947 | March 2035 | product |
| 10959948 | March 2035 | product |
| 10959949 | March 2035 | product |
| 11638692 | March 2035 | product |
| 10493028 | March 2035 | product |
| 10688046 | March 2035 | product |
| 10959946 | March 2035 | product |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.